ADAR1 Capital Management »

Acasti Pharma shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Acasti Pharma (ACST) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Acasti Pharma

Tip: Access up to 7 years of quarterly data

All positions including Acasti Pharma held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acasti Pharma by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.8M 960k 2.92
2024-03-31 $745k 217k 3.43
2023-12-31 $100k 35k 2.89

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Acasti Pharma

AIGH Capital Management
Bank of America Corporation
Renaissance Technologies
Tower Research Capital
National Bank Of Canada /fi/
Royal Bank of Canada
UBS Group
Federation des caisses Desjardins du Quebec
Jpmorgan Chase & Co

View all funds holding Acasti Pharma